Form 4 for BHC Bausch Health Companies Inc.
Accepted 2025-07-16 00:00:00 ET · period of report 2025-07-15 · accession 0001127602-25-019278 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-16 | 2025-07-15 | BHC | Lenar Aimee J. | EVP, US Pharma | F - Tax | $6.42 | -22.7K | 229.9K | -9% | -$146.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2025-07-15 | F | D | 22,736 | $6.42 | 229,927 | D | — | — | (F1) This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. |